NDC 52959-675

SENEXON-S

Docusate Sodium -sennosides

SENEXON-S is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Docusate Sodium; Sennosides A And B.

Product ID52959-675_e57a4e72-fd3d-44fa-96ca-06ea1d477cc8
NDC52959-675
Product TypeHuman Otc Drug
Proprietary NameSENEXON-S
Generic NameDocusate Sodium -sennosides
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2011-03-16
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameH.J. Harkins Company, Inc.
Substance NameDOCUSATE SODIUM; SENNOSIDES A AND B
Active Ingredient Strength50 mg/1; mg/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 52959-675-60

60 TABLET, COATED in 1 BOTTLE, PLASTIC (52959-675-60)
Marketing Start Date2011-03-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52959-675-08 [52959067508]

SENEXON-S TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-03-16
Inactivation Date2020-01-31

NDC 52959-675-00 [52959067500]

SENEXON-S TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-03-16
Inactivation Date2020-01-31

NDC 52959-675-60 [52959067560]

SENEXON-S TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-03-16
Inactivation Date2020-01-31

NDC 52959-675-02 [52959067502]

SENEXON-S TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-03-16
Inactivation Date2020-01-31

NDC 52959-675-30 [52959067530]

SENEXON-S TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-03-16
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DOCUSATE SODIUM50 mg/1

OpenFDA Data

SPL SET ID:f6e923e8-46e8-4287-bd62-5b954829cd73
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1248013
  • 998740
  • NDC Crossover Matching brand name "SENEXON-S" or generic name "Docusate Sodium -sennosides"

    NDCBrand NameGeneric Name
    0536-1247Senexon-SDocusate Sodium 50mg and Sennosides 8.6mg
    0536-4086SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    0615-7773SENEXON-Sdocusate sodium-sennosides tablet
    0615-8083SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    0615-8331Senexon-SDocusate Sodium 50mg and Sennosides 8.6mg
    33261-749SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    52959-675SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    68788-9407SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    43063-818Docusate Sodium with SennosidesDOCUSATE SODIUM -SENNOSIDES

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.